|
Twitter
|
Facebook
|
Google+
|
VKontakte
|
LinkedIn
|
Viadeo
|
English
|
Français
|
Español
|
العربية
|
 
International Journal of Innovation and Applied Studies
ISSN: 2028-9324     CODEN: IJIABO     OCLC Number: 828807274     ZDB-ID: 2703985-7
 
 
Tuesday 25 September 2018

About IJIAS

News

Submission

Downloads

Archives

Custom Search

Contact

Connect with IJIAS

  Now IJIAS is indexed in EBSCO, ResearchGate, ProQuest, Chemical Abstracts Service, Index Copernicus, IET Inspec Direct, Ulrichs Web, Google Scholar, CAS Abstracts, J-Gate, UDL Library, CiteSeerX, WorldCat, Scirus, Research Bible and getCited, etc.  
 
 
 

An Analysis on Biosimilars


Volume 7, Issue 1, July 2014, Pages 376–381

 An Analysis on Biosimilars

W. Dorisa Jenifer1, M.S. Gincy2, and S. P.G. Indu3

1 Department of Biotechnology, Udaya School of Engineering, Udaya Nagar, Vellamoodi, Kanyakumari Dist-629204, India
2 Department of Biotechnology, Udaya School of Engineering, Udaya Nagar, Vellamoodi, Kanyakumari Dist-629204, India
3 Department of Biotechnology, Udaya School of Engineering, Udaya Nagar, Vellamoodi, Kanyakumari Dist-629204, India

Original language: English

Received 24 May 2014

Copyright © 2014 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract


Production of biosimilars, similar to the original pharmaceuticals that faces certain challenges like possible need for unique naming to differentiate the various biopharmaceutical products, regulatory framework and commercial opportunities have made the researchers in head over heels to design the appropriate one. Clinical applications have to be the main target that relies on cost-effectiveness and market value.

Author Keywords: biosimilars, biopharmaceutical products, clinical applications, market value.


How to Cite this Article


W. Dorisa Jenifer, M.S. Gincy, and S. P.G. Indu, “An Analysis on Biosimilars,” International Journal of Innovation and Applied Studies, vol. 7, no. 1, pp. 376–381, July 2014.